Cocrystal Pharma
COCP
13 hedge funds and large institutions have $1.1M invested in Cocrystal Pharma in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.75% more ownership
Funds ownership: 0% → 0.75% (+0.75%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Emory University
Atlanta,
Georgia
|
+$795K |
| 2 |
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$66.2K |
| 3 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$43.3K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$20.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.5K |
Top Sellers
COCP Hedge Fund Activity: Q1 2018 in Review
13 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q1 2018, worth a combined $1.1M.
Buyers outnumbered sellers: 13 funds opened new COCP positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Emory University, opening a new position worth an estimated $795K.
- 13 institutional investors held Cocrystal Pharma (COCP) as of Q1 2018, up from 0 in Q4 2017.
- Funds reported $1.1M of Cocrystal Pharma stock for Q1 2018.
- 13 funds opened new Cocrystal Pharma positions in Q1 2018 and 0 closed out, a net change of +13 holders.
- The largest Cocrystal Pharma buyer in Q1 2018 was Emory University, an estimated $795K added.
Based on aggregated 13F filings for Q1 2018.